News 2021/06/01 The Spiez Laboratory at the heart of the WHO’s BioHub system The Spiez Laboratory will be the first facility to be part of the WHO’s BioHub system, an infrastructure that will facilitate the timely sharing ...
Aktuell 2023/05/23 Universität Basel und RocketVax stellen neuen COVID-Impfstoff vor Forschende der Universität Basel haben mit dem Biotech-Start-up RocketVax ein neues Konzept für einen Corona-Impfstoff entwickelt. Er beruht auf ...
Aktuell 2022/12/13 Neues Empa-Verfahren zeigt Virensterben in Masken Mithilfe eines an der Eidgenössischen Materialprüfungs- und Forschungsanstalt (Empa) entwickelten Verfahrens können Forschende vergleichen, welch...
Success stories 2023/05/25 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
Actualités 2021/06/01 Le Laboratoire de Spiez au cœur du système BioHub de l’OMS Le Laboratoire de Spiez sera la première installation du système BioHub de l’OMS, une infrastructure qui facilitera le partage rapide de virus et...
News 2020/04/14 Geneva world leading laboratory CERN establishes task force to fight Covid-19 The canton of Geneva’s world leading laboratory in particle physics CERN has established a task force to identify and support contributions from ...
News 2020/04/17 Roche launches new antibody test on the market The Basel-based pharmaceutical and diagnostics group Roche has developed a new test to verify the presence of antibodies against the coronav...
Actualités 2020/04/14 Le laboratoire genevois CERN crée un comité d’action pour lutter contre le Covid-19 Le CERN, le principal laboratoire de physique des particules du canton de Genève, a mis sur pied un groupement d'action pour identifier et souten...
News 2023/05/23 University of Basel and RocketVax present new COVID vaccine Researchers from the University of Basel have developed a new concept for a COVID vaccine in collaboration with the biotech start-up RocketVax. I...
Aktuell 2020/04/17 Roche bringt Antikörpertest auf den Markt Der Basler Pharma- und Diagnostikkonzern Roche hat einen neuen Test zum Nachweis von Antikörpern gegen das Coronavirus entwickelt. Er kann dazu b...
Webinar 2020/11/11 Brazil: How to enter the market and optimize your structure post-covid-19 Are you already exporting or looking to export to Brazil? Learn how Swiss companies can enter the market or optimize their current local structur...
News 2022/12/13 New Empa method indicates virus death in face masks With the help of a method developed at the Swiss Federal Laboratories for Materials Science and Technology (Empa), researchers can compare which ...
News 2021/10/27 The University of Bern has developed a non-contagious SARS-CoV-2 model Researchers of the University of Bern and the Rockefeller University have developed a non-contagious SARS-CoV-2 model that makes it easier to cha...
News 2023/02/08 RocketVax raises fresh capital The biotech start-up RocketVax has successfully closed another financing round. This additional funding will primarily be used to further develop...
Aktuell 2021/12/06 Roche-Tests können Omikron erkennen Die Roche-Tochter TIB Molbiol hat neue Corona-Tests entwickelt, die auch die neue Omikron-Variante erkennen können. Diese Tests sollen der Forsch...
News 2021/12/01 Predictive analytics start-up Kido Dynamics raises EUR 1.9 million Kido Dynamics, an EPFL spin-off that helps multiple industries and public institutions to understand and predict people’s mobility, has secured E...
Aktuell 2020/05/20 Empa setzt Standards für Stoffmasken Empa-Forschende haben gemeinsam mit der Schweizer Textilbranche Technologien und Qualitätsstandards für Schutzmasken aus Stoff entwickelt. Damit ...